Sensoreal development of a Point of Care diagnostic device

Sensoreal is excited to announce that the company has begun working on the development of a Point of Care diagnostic device capable of differentiating between bacterial and viral infections. This project has been partially funded by Canada’s Innovative Solutions, answering the challenge to develop tools to combat the rise of Antimicrobial Resistance (AMR). Link